A revocation to this notice was published on 16 May 2023, Notice No. 2023-go2024.

Notice Title

Full Exemption of Certain COVID-19 Point-of-care Tests Under the COVID-19 Public Health Response (Point-of-care Tests) Order 2021

Pursuant to Clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, Robyn Shearer, Acting Director-General of Health, exempt the following point-of-care rapid antigen test from all prohibitions under clause 7 of the Order.

Product name(s): SARS-CoV-2 Antigen Kit (Colloidal Gold)

Manufacturer (country): Goldsite Diagnostics, Inc. (China)

Sample type(s): Nasal swab

Product configuration: Self-test of any package size

Dated at Wellington this 26th day of May 2022.

ROBYN SHEARER, Acting Director-General of Health, Ministry of Health.